Inhibitor Therapeutics, Inc. Long-term Line of Credit
Inhibitor Therapeutics, Inc. (INTI) had Long-term Line of Credit of $0 as of 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:LineOfCredit · last filed 2022-03-30
- 2021-12-31: Long-term Line of Credit $0.00.
- 2021-09-30: Long-term Line of Credit $38.50K.
- 2021-06-30: Long-term Line of Credit $96.25K.
- 2021-03-31: Long-term Line of Credit $104.00K.
| Period end | Long-term Line of Credit |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-30 |
| 2021-09-30 | $38.50K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $96.25K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $104.00K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $55.00K 10-K · filed 2022-03-30 |